Inhibition of neuronal nitric oxide synthase reduces isoflurane MAC and motor activity even in nNOS knockout mice

British Journal of Anaesthesia

Volumn 96, Issue 3, 2006, Pages 361-366

  Engelhardt, T ^a   Lowe, P R ^a   Galley, H F ^a   Webster, N R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anaesthetics volatile, isoflurane; Inhibitor, 7 NI; Isoform, nNOS; Mice, open field

Indexed keywords

7 NITROINDAZOLE; ARGININE; CYCLIC GMP; INHALATION ANESTHETIC AGENT; ISOFLURANE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANALYSIS OF VARIANCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; INHIBITION KINETICS; KNOCKOUT MOUSE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MOTOR ACTIVITY; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RIGHTING REFLEX; STATISTICAL SIGNIFICANCE; WILD TYPE;

EID: 33244484356     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/ael010     Document Type: Article

References (24)

1. Johns RA, Moscicki JC, DiFazio CA. Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. A role for nitric oxide in mediating consciousness? Anesthesiology 1992; 77: 779-84
2. Sonner JM, Antognini JF, Dutton RC, et al. Inhaled anesthetics and immobility: Mechanisms, mysteries, and minimum alveolar anesthetic concentration. Anesth Analg 2003; 97: 718-40
3. Pajewski TN, DiFazio CA, Moscicki JC, Johns RA. Nitric oxide synthase inhibitors, 7-nitro indazole and nitroG-L-arginine methyl ester, dose dependently reduce the threshold for isoflurane anesthesia. Anesthesiology 1996; 85: 1111-19
4. Ichinose F, Huang PL, Zapol WM. Effects of targeted neuronal nitric oxide synthase gene disruption and nitroG-L-arginine methylester on the threshold for isoflurane anesthesia. Anesthesiology 1995; 83: 101-8
5. Ichinose F, Mi WD, Miyazaki M, Onouchi T, Goto T, Morita S. Lack of correlation between the reduction of sevoflurane MAC and the cerebellar cyclic GMP concentrations in mice treated with 7-nitroindazole. Anesthesiology 1998; 89: 143-8
6. Fukuda T, Saito S, Sato S, Harukuni I, Toyooka H. Halothane minimum alveolar anesthetic concentration and neuronal nitric oxide synthase activity of the dorsal horn and the locus ceruleus in rats. Anesth Analg 1999; 89: 1035-9
7. 50 and minimum alveolar concentration during sevoflurane anaesthesia in rats. Eur J Anaesthesiol 2003; 20: 212-19
8. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75: 1273-86
9. Eliasson MJL, Blackshaw S, Schell MJ, Snyder SH. Neuronal nitric oxide synthase alternatively spliced forms: Prominent functional localizations in the brain. Proc Natl Acad Sci USA 1997; 94: 3396-401
10. Δ/Δ mice). Mol Brain Res 2000; 85: 13-23
11. Volke V, Soosaar A, Koks S, Bourin M, Mannisto P.T. Vazar E. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology (Berl) 1997; 131: 399-405
12. Araki T, Mizutani H, Matsubara M, Imai Y, Mizugaki M, Itoyama Y. Nitric oxide synthase inhibitors cause motor deficits in mice. Eur Neuropsychopharmacol 2001; 11: 125-33
13. Crawley JN. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 1999; 835: 18-26
14. Adachi T, Kurata J, Nakao S, et al. Nitric oxide synthase inhibitor does not reduce minimum alveolar anesthetic concentration of halothane in rats. Anesth Analg 1994; 78: 1154-7
15. Adachi T, Shinomura T, Nakao S, et al. Chronic treatment with nitric oxide synthase (NOS) inhibitor profoundly reduces cerebellar NOS activity, cyclic guanosine monophosphate but does not modify minimum alveolar anesthetic concentration. Anesth Analg 1995; 81: 862-5
16. Klatt P, Schmidt K, Brunner F, Mayer B. Inhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation. J Biol Chem 1994; 269: 1674-80
17. Klatt P, Schmid M, Leopold E, Schmidt K, Werner ER, Mayer B. The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, and allosteric interaction with the substrate domain. J Biol Chem 1994; 269: 13861-6
18. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthase: Structure, function and inhibition. Biochem J 2001; 357: 593-615
19. Moore PK, Babbedge RC, Wallace P, Gaffen ZA, Hart SL. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits antinociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 1993; 108: 296-7
20. Yoshida T, Limmroth V, Irikura K, Moskowitz MA. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J Cereb Blood Flow Metab 1994; 14: 924-9
21. Barañano DE, Snyder SH. Neural roles for heme oxygenase: Contrast to nitric oxide synthase. Proc Natl Acad Sci USA 2001; 98: 10996-1002
22. Sonner JM, Gong D, Eger EI II. Naturally occurring variability in anesthetic potency among inbred mouse strains. Anesth Analg 2000; 91: 720-6
23. Hascoet M, Bourin M. A new approach to the light/dark test procedure in mice. Pharmacol Biochem Behav 1998; 60: 645-53
24. Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: A review. Behav Brain Res 2001; 125: 141-9